A Phase 1 Study of Vinorelbine Liposomes Injection (VLI) for Treatment in Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease.
Phase of Trial: Phase I
Latest Information Update: 24 Sep 2015
At a glance
- Drugs Vinorelbine (Primary)
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma; Solid tumours
- Focus Adverse reactions
- Sponsors Spectrum Pharmaceuticals
- 19 May 2015 Planned End Date changed from 1 Dec 2014 to 1 Aug 2015 as per ClinicalTrials.gov.
- 19 May 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Jun 2015 as per ClinicalTrials.gov.
- 28 Mar 2014 Planned End Date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.